抗菌肽抗菌机理及其在糖尿病足溃疡局部抗感染治疗中的应用

doi:10.3969/j.issn.0258-8021.2024.06.012

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (2831 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Infectious diseases caused by pathogenic microorganisms can cause inflammation and tissue damage, which slow down the healing process, especially for chronic wounds such as diabetic feet and traumatic ulcers. Patients often suffer from impaired immune function combining with factors such as vascular disease and neuropathy around the wound surface. Therefore, bacteria are prone to multiply in the infected wound site and form biofilms, thus making it difficult for bacteria to be removed, increasing the severity of trauma site infection, and seriously affecting the subsequent life of patients. Antimicrobial peptides, as a class of active small molecule polypeptides, can achieve broad-spectrum antibacterial effect by destroying bacterial cell membrane and other methods. Some antimicrobial peptides can inhibit or destroy biofilms by inhibiting bacterial adhesion, interfering with the formation of biofilm components and interfering with bacterial quorum sensing. Combined with anti-inflammatory, immunomodulatory and other multi-functions, the peptides have been widely used in the treatment of anti-infection and chronic trauma. This review introdced antibacterial and anti-biofilm mechanisms and summarized applications of the antimicrobial peptides in anti-infection treatments of diabetic foot ulcers, and analyzed the advantages and disadvantages of the various applications. Accordingly, development prospects of the antimicrobial peptides were proposed, aiming to provide practical approaches for the anti-infection treatment of diabetic foot ulcers.

Key words： antimicrobial peptides anti-infection anti-biofilm chronic wound healing

Received: 06 May 2023

PACS:

R318

About author:: ^#Member, Chinese Society of Biomedical Engineering

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Zhang Zeyu
	Liu Yufei
	Zhou Jie
	Liu Xiangsheng
	Xu Jun
	Wang Shufang

Cite this article:

Zhang Zeyu,Liu Yufei,Zhou Jie, et al. Antibacterial Mechanism of Antibacterial Peptide and its Application in Local Anti-InfectionTreatment of Diabetes Foot Ulcer[J]. Chinese Journal of Biomedical Engineering, 2024, 43(6): 751-758.

URL:

http://cjbme.csbme.org/EN/10.3969/j.issn.0258-8021.2024.06.012 OR http://cjbme.csbme.org/EN/Y2024/V43/I6/751

[1] Long M, Montserrat VR, Wen Q, et al. An essential role of NRF2 in diabetic wound healing[J].Diabetes, 2016, 65(3): 780-793.
[2] Saluja S, Anderson SG, Hambleton I, et al. Foot ulceration and its association with mortality in diabetes mellitus: a meta‐analysis[J]. Diabetic Medicine, 2020, 37(2): 211-218.
[3] Shen Qiuyan, Lin Dini, Zhu Hong, et al. Clinical distribution and antimicrobial resistance analysis of 754 pathogenic bacteria in diabetic foot infection[J]. Chinese Medical Journal 2014, 94(12): 889-894.
[4] Mendelson M, Matsoso MP. The World Health Organization global action plan for antimicrobial resistance[J]. South African Medical Journal, 2015, 105(5): 325-325.
[5] Salas CE, Badillo-Corona JA, Ramírez-Sotelo G, et al. Biologically active and antimicrobial peptides from plants[J]. BioMed Research International, 2015,2015:102129.
[6] Wang Yipeng, Lai Ren. Insect antimicrobial peptides: structures, properties and gene regulation[J]. Zoological Research, 2010, 31(1): 27-34.
[7] Robert EW, Gill D. The role of antimicrobial peptides in animal defenses[J]. Trends in Microbiology, 2000, 97(16): 8856-8861.
[8] Conlon JM, Kolodziejek J, Nowotny N. Antimicrobial peptides from ranid frogs: taxonomic and phylogenetic markers and a potential source of new therapeutic agents[J]. Biochimica et Biophysica Acta-Proteins and Proteomics, 2003, 1696(1): 1-14.
[9] Montesinos E, Badosa E, Cabrefiga J. Antimicrobial peptides for plant disease control[M]. Small Wonders: Peptides for Disease Control. 2012: 235-261.
[10] Mishra B, Reiling S, Zarena D, et al. Host defense antimicrobial peptides as antibiotics: design and application strategies[J]. Current Opinion in Chemical Biology, 2017, 38: 87-96.
[11] Magana M, Pushpanathan M, Santos AL, et al. The value of antimicrobial peptides in the age of resistance[J]. The Lancet Infectious Diseases, 2020, 9: 216-230.
[12] Browne K, Chakraborty S, Chen RX. A new era of antibiotics: the clinical potential of antimicrobial peptides[J]. International Journal of Molecular Sciences, 2020, 21(19): 1-14.
[13] Segev-Zarko L, Saar-Dover R, Brumfeld V, et al. Mechanisms of biofilm inhibition and degradation by antimicrobial peptides[J]. The Biochemical Journal, 2015, 468(2): 259-270.
[14] Overhage J, Campisano A, Bains M, et al. Human host defense peptide LL-37 prevents bacterial biofilm formation[J]. Infection and Immunity, 2008, 76(9): 4176-4182.
[15] Ansari JM, Abraham NM, Massaro J, et al. Anti-biofilm activity of a self-aggregating peptide against streptococcus mutans[J]. Front Microbiol, 2017, 8: 488-495.
[16] Buonocore F, Picchietti S, Porcelli F, et al. Fish-derived antimicrobial peptides: activity of a chionodracine mutant against bacterial models and human bacterial pathogens[J]. Developmental and Comparative Immunology, 2019, 96: 9-17.
[17] Otvos L, Ostorhazi E. Therapeutic utility of antibacterial peptides in wound healing[J]. Expert Review of Anti-infective Therapy, 2015, 13(7): 871-881.
[18] Lin Ping, Li Yong, Dong Ke, et al. The antibacterial effects of an antimicrobial peptide human β-defensin 3 fused with carbohydratebinding domain on Pseudomonas aeruginosa PA14[J].Current Microbiology, 2015, 71(2): 170-176.
[19] Haney EF, Mansour SC, Hancock RE. Antimicrobial peptides: an introduction[J]. Methods in Molecular Biology, 2017, 1548: 3-22.
[20] Rezaei N, Hamidabadi HG, Khosravimelal S, et al. Antimicrobial peptides-loaded smart chitosan hydrogel: release behavior and antibacterial potential against antibiotic resistant clinical isolates[J]. International Journal of Biological Macromolecules, 2020, 164: 855-862.
[21] Kumar P, Kizhakkedathu JN, Straus SK. Antimicrobial peptides: diversity, mechanism of action and strategies to improve the activity and biocompatibility in vivo[J]. Biomolecules, 2018, 8(1): 4-11.
[22] Sekiya Y, Sakashita S, Shimizu K, et al. Channel current analysis estimates the pore-formation and the penetration of transmembrane peptides[J]. Analyst, 2018, 143(15): 3540-3543.
[23] Prashant K, Jayachandran K, Suzana S. Antimicrobial peptides: diversity, mechanism of action and strategies to improve the activity and biocompatibility in vivo[J]. Biomolecules, 2018, 8(1):4-12.
[24] Saravanan R, Li Xiaoli, Lim K, et al. Design of short membrane selective antimicrobial peptides containing tryptophan and arginine residues for improved activity, salt-resistance, and biocompatibility[J]. Biotechnol Bioeng, 2014, 1: 1-9.
[25] Hashem YA, Amin HM, Essam TM, et al. Biofilm formation in enterococci: Genotype-phenotype correlations and inhibition by vancomycin[J]. Scientific Reports, 2017, 7(1): 5733-5733.
[26] Luo Ying, Song Yuzhu. Mechanism of antimicrobial peptides: antimicrobial, anti-inflammatory and antibiofilm activities[J]. International Journal of Molecular Sciences, 2021, 22(21): 1-20.
[27] Haney EF, Trimble MJ, Cheng Jietao, et al. Critical assessment of methods to quantify biofilm growth and evaluate antibiofilm activity of host defence peptides[J]. Biomolecules, 2018, 8(2): 1-19.
[28] Muhammad MH, Idris AL, Fan Xiao, et al. Beyond risk: bacterial biofilms and their regulating approaches[J]. Frontiers in Microbiology, 2020, 11: 928-935.
[29] Fuente-Núñez CDL, Korolik V, Bains M, et al. Inhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptide[J]. Antimicrobial Agents and Chemotherapy, 2012, 56(5): 2696-2704.
[30] Skariyachan S, Sridhar VS, Packirisamy S, et al. Recent perspectives on the molecular basis of biofilm formation by Pseudomonas aeruginosa and approaches for treatment and biofilm dispersal[J]. Folia Microbiologica, 2018, 63(4): 413-432.
[31] Wilton M, Charron-Mazenod L, Moore R, et al. Extracellular DNA acidifies biofilms and induces aminoglycoside resistance in Pseudomonas aeruginosa[J]. Antimicrobial Agents and Chemotherapy, 2016, 60(1): 544-553.
[32] Palchevskiy V, Finkel SE. Escherichia coli competence gene homologs are essential for competitive fitness and the use of DNA as a nutrient[J]. Journal of Bacteriology, 2006, 188(11): 3902-3910.
[33] Wang Siyu, Han Dengcheng, Song Chao, et al. Membrane biofouling retardation by zwitterionic peptide and its impact on the bacterial adhesion[J]. Environmental Science and Pollution Research, 2019, 26(16): 16674-16681.
[34] Brancatisano FL, Maisetta G, Di LM, et al. Inhibitory effect of the human liver-derived antimicrobial peptide hepcidin 20 on biofilms of polysaccharide intercellular adhesion PIA-positive and PIA-negative strains of Staphylococcus epidermidis[J]. Biofouling, 2014, 30(4): 435-446.
[35] Sethupathy S, Prasath KG, Ananthi S, et al. Proteomic analysis reveals modulation of iron homeostasis and oxidative stress response in Pseudomonas aeruginosa PAO1 by curcumin inhibiting quorum sensing regulated virulence factors and biofilm production[J]. Journal of Proteomics, 2016, 145: 112-126.
[36] Brackman G, Cos P, Maes L, et al. Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo[J]. Antimicrobial Agents and Chemotherapy, 2011, 55(6): 2655-2661.
[37] Singh VP, Bali A, Singh N, et al. Advanced glycation end products and diabetic complications[J]. The Korean Journal of Physiology and Pharmacology, 2014, 11(1): 1-14.
[38] Srivastava P, Sondak T, Sivashanmugam K, et al. A review of immunomodulatory reprogramming by probiotics in combating chronic and acute diabetic foot ulcers (DFUs)[J]. Pharmaceutics, 2022, 14(11): 1-31.
[39] Zou Mengchen, Cai Yulan, Hu Ping, et al. Analysis of the composition and functions of the microbiome in diabetic foot osteomyelitis based on 16S rRNA and metagenome sequencing technology[J]. Diabetes, 2020, 69(11): 2423-2439.
[40] Hancock R, Nijnik A, Philpott DJ. Modulating immunity as a therapy for bacterial infections[J]. Nature Reviews Microbiology, 2012, 10(4): 243-254.
[41] Gopinath K, Kalle M, Mrgelin M, et al. Anti-endotoxic and antibacterial effects of a dermal substitute coated with host defense peptides[J]. Biomaterials, 2015, 53: 415-425.
[42] Lipsky BA, Holroyd KJ, Zasloff M. Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream[J]. Clinical Infectious Diseases, 2008, 47(12): 1537-1542.
[43] Ezra MC, Scott ND, Crystal ND, et al. Komodo dragon-inspired synthetic peptide DRGN-1 promotes wound-healing of a mixed-biofilm infected wound[J]. npj Biofilms and Microbiomes, 2017, 3(9): 1-13.
[44] Oh JK, Siegwart DJ, Lee H, et al. Biodegradable nanogels prepared by atom transfer radical polymerization as potential drug delivery carriers: synthesis, biodegradation, in vitro release, and bioconjugation[J]. Journal of the American Chemical Society,2007, 129(18): 5939-5945.
[45] Khan A, Xu Miao, Wang Tengjiao, et al. Catechol cross-linked antimicrobial peptide hydrogels prevent multidrug-resistant Acinetobacter baumannii infection in burn wounds[J]. Bioscience Reports, 2019, 39(6): 1-15.
[46] Lin Zefeng, Wu Tingting, Wang Wanshun, et al. Biofunctions of antimicrobial peptide-conjugated alginate/hyaluronic acid/collagen wound dressings promote wound healing of a mixed-bacteria-infected wound[J]. International Journal of Biological Macromolecules, 2019, 140: 330-342.
[47] Gao Jingyu. One step synthesis of antimicrobial peptide protected silver nanoparticles: the core-shell mutual enhancement of antibacterial activity[J]. Colloids and Surfaces B: Biointerfaces, 2019, 186: 235-245.
[48] Garcia-Orue I, Gainza G, Girbau C, et al. LL37 loaded nanostructured lipid carriers (NLC): a new strategy for the topical treatment of chronic wounds[J]. European Journal of Pharmaceutics and Biopharmaceutics, 2016, 108: 310-316.
[49] Gawande PV, Leung KP, Madhyastha S. Antibiofilm and antimicrobial efficacy of DispersinB^-KSL-W peptide-based wound gel against chronic wound infection associated bacteria[J]. Current Microbiology, 2014, 68(5): 635-641.
[50] Shang Dejing, Liu Yue, Jiang Fengquan, et al. Synergistic antibacterial activity of designed trp-containing antibacterial peptides in combination with antibiotics against multidrug-resistant staphylococcus epidermidis[J]. Frontiers in Microbiology, 2019, 10: 2719-2719.
[51] Wilson SS, Wiens ME, Holly MK, et al. Defensins at the mucosal surface: latest insights into defensin-virus interactions[J]. Journal of Virology, 2016, 90(11): 5216-5218.
[52] Costa AD, Pereira AM, Gomes AC, et, al. Production of bioactive hepcidin by recombinant DNA tagging with an elastin-like recombinamer[J]. New Biotechnology, 2018, 46: 45-53.
[53] Angelo I, Casciaro B, Miro A, et al. Overcoming barriers in Pseudomonas aeruginosa lung infections: engineered nanoparticles for local delivery of a cationic antimicrobial peptide[J]. Colloids and Surfaces, B. Biointerfaces, 2015, 135: 717-725.